Question

The Eurasian healthcare market targeted by the Indo–CIS Pharma-Nutraceutical Corridor is estimated to be worth approximately how much?

A USD 3–5 billion Correct Answer Incorrect Answer
B USD 3–5 billion Correct Answer Incorrect Answer
C USD 7–10 billion Correct Answer Incorrect Answer
D USD 10–12 billion Correct Answer Incorrect Answer
E USD 12–15 billion Correct Answer Incorrect Answer

Solution

The corridor aims to tap into the Eurasian healthcare market valued at approximately USD 7–10 billion, expanding opportunities for Indian pharmaceutical and nutraceutical companies.

Practice Next
ask-question